Filing Details
- Accession Number:
- 0001127602-22-008299
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-04 16:58:45
- Reporting Period:
- 2022-03-02
- Accepted Time:
- 2022-03-04 16:58:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 885590 | Bausch Health Companies Inc. | BHC | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1749876 | F Joseph Gordon | 400 Somerset Corporate Blvd. Bridgewater NJ 08807 | Pres&Co-Head Bausch&Lomb/Int'l | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares, No Par Value | Disposition | 2022-03-02 | 11,077 | $23.37 | 101,102 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 27, 2021.
Billionaire Hedge Funds
